Study of Pegylated Human Recombinant Arginase for Liver Cancer (BCT-100-002)

Clinical trial NCT01092091 · COMPLETED

Trial details

NCT number: NCT01092091
Sponsor: Bio-Cancer Treatment International Limited
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Neoplasm Hepatocellular Carcinoma

Start date: 2010-03-01
Primary completion: 2012-02-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.